HYRIMOZ

This brand name is authorized in Albania, Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom

Active ingredients

The drug HYRIMOZ contains one active pharmaceutical ingredient (API):

1 Adalimumab UNII FYS6T7F842 - ADALIMUMAB

Adalimumab binds specifically to TNF and neutralizes the biological function of TNF by blocking its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab also modulates biological responses that are induced or regulated by TNF, including changes in the levels of adhesion molecules responsible for leukocyte migration (ELAM-1, VCAM-1, and ICAM-1 with an IC50 of 0.1-0.2 nM). Read about Adalimumab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AB04	Adalimumab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 664/237, 664/237a
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10399H, 10400J, 10412B, 10413C, 10419J, 10420K, 10944B, 10955N, 10960W, 10961X, 12325Q, 12326R, 12327T, 12328W, 12329X, 12330Y, 12331B, 12333D, 12334E, 12348X, 12352D, 12353E, 12355G, 12356H, 12365T, 12366W, 12367X, 12368Y, 12369B, 12370C, 12384T, 12385W, 12386X, 12387Y, 12388B, 12401Q, 12402R, 12403T, 12415K, 12416L, 12420Q, 12434K, 12437N, 12438P, 5281Y, 5282B, 5283C, 5284D, 8737W, 8741C, 8963R, 8964T, 8965W, 8966X, 9033K, 9034L, 9077R, 9078T, 9099X, 9100Y, 9101B, 9102C, 9103D, 9104E, 9188N, 9189P, 9190Q, 9191R, 9425C, 9426D, 9427E, 9428F, 9662M, 9663N, 9679K, 9680L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 511520070072107, 511520070072207
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 13974778, 13974784, 13974790, 13974809, 15300765, 15300771, 15317033, 15317062, 15317079, 15317085, 15530086, 15530092, 15530100, 15530117, 15563105, 15563111, 15607452, 15607535, 15863020, 15863037, 15863043, 15863066, 15870126, 15870132, 15870149, 15870161, 16002679, 16002691, 16009948, 16009954, 16009960, 16009977, 16018255, 16018261, 16018278, 16018284, 16018462, 16018479, 16018485, 16018491, 16388779, 16388785, 16388791, 16388816, 16759448, 16759454, 16759460, 16759477, 16794686, 16958001, 16958018, 17294721, 17294738, 17312560, 17906986, 17921307
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 197-MBE-0521
Country: EE	Ravimiamet	Identifier(s): 1777293, 1777305, 1777316, 1777327, 1777338, 1777349, 1816398
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181286001, 1181286004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 371157, 542236, 592241
Country: FR	Base de données publique des médicaments	Identifier(s): 63795537, 66112231
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 362344, 362346
Country: HK	Department of Health Drug Office	Identifier(s): 67013, 67014
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8809, 8810
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086031, 1086032, 1086033, 1086034, 1086035, 1086036, 1089891
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 106348, 167207, 84492
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20527, 20528
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100408933, 100452941
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64999001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681428951499, 8681428951505